Evidence map›Paper›PMID 30696325›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2019

Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone-chalcone and isatin-chalcone inhibitors probing the S2 active site pocket.

Koffi N'Guessan Placide Gabin Allangba, Mélalie Keita, Raymond Kre N'Guessan, Eugene Megnassan, Vladimir Frecer, Stanislav Miertus

Abstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Frontiers in chemistry · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Koffi N'Guessan Placide Gabin Allangbaa Laboratoire de Physique Fondamentale et Appliquée (LPFA) , University of Abobo Adjamé (now Nangui Abrogoua) , Abidjan , Côte d'Ivoire.
Mélalie Keitaa Laboratoire de Physique Fondamentale et Appliquée (LPFA) , University of Abobo Adjamé (now Nangui Abrogoua) , Abidjan , Côte d'Ivoire.
Raymond Kre N'Guessana Laboratoire de Physique Fondamentale et Appliquée (LPFA) , University of Abobo Adjamé (now Nangui Abrogoua) , Abidjan , Côte d'Ivoire.
Eugene Megnassana Laboratoire de Physique Fondamentale et Appliquée (LPFA) , University of Abobo Adjamé (now Nangui Abrogoua) , Abidjan , Côte d'Ivoire.
Vladimir Frecerc ICS-UNIDO , Trieste , Italy.
Stanislav Miertusc ICS-UNIDO , Trieste , Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report computer-aided design of new lactone-chalcone and isatin-chalcone (HLCIC) inhibitors of the falcipain-2 (PfFP-2). 3D models of 15 FP-2:HLCIC1-15 complexes with known observed activity (IC

Indexed as

Drug DesignCatalytic DomainChalconesComputer-Aided DesignCysteine EndopeptidasesCysteine Proteinase InhibitorsInhibitory Concentration 50IsatinLactonesModels, MolecularMolecular ProbesPlasmodium falciparumQuantitative Structure-Activity RelationshipThermodynamicsChalconesCysteine EndopeptidasesCysteine Proteinase Inhibitorsfalcipain 2IsatinLactonesMolecular ProbesFalcipain-2molecular modellingpharmacokineticspharmacophorePlasmodium falciparumQSAR modelvirtual library

Identifiers

PMID30696325
PMCPMC6352947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.